InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
고수익 성장
회사의 순이익은 업계 선두를 달리고 있으며, 최근 연간 순이익은 미화 143.44M에 달합니다.
과소 평가된
회사의 최신 PE은 23.82로, 최근 3년 기준 낮은 백분위 범위에 속합니다.
기관 매도
최신 기관 보유 주식 수는 16.62M주이며, 전 분기 대비 11.38% 감소했습니다.
ETHSX가 보유
스타 투자자 ETHSX이(가) 이 주식 1.28K주를 보유하고 있습니다.
시장 활동 감소
회사는 투자자들의 관심이 줄어들어, 최근 20일간 회전율이 -0.12입니다.